Zhanxin Yin

Zhanxin Yin

Auto-generated profile, based on publicly available information

Zhanxin Yin

National Infection Service Public Health England London UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2014 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
MLMingwu Li
Mingwu Li
MBMing Bai
Ming Bai
XQXingshun Qi
Xingshun Qi
KLKai Li
Kai Li
ZYZhanxin Yin
Zhanxin Yin
GHGuohong Han
Guohong Han

11 November 2019 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JFJiahao Fan
Jiahao Fan
QWQiuhe Wang
Qiuhe Wang
BLBohan Luo
Bohan Luo
HCHui Chen
Hui Chen
ZWZhengyu Wang
Zhengyu Wang
GHGuohong Han
Guohong Han

30 April 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EWEnxin Wang
Enxin Wang
DXDongdong Xia
Dongdong Xia
WBWei Bai
Wei Bai
JYJie Yuan
Jie Yuan
XLXiaomei Li
Xiaomei Li
LLLei Liu
Lei Liu
To validate the robust predictive values of tumor vascularity and hand-foot-skin reaction (HFSR) in combination treatment of transarterial chemoembolization (TACE) and sorafenib for patients with intermediate hepatocellular carcinoma (HCC), and then select the potential candidates who would survive best from such treatment. A total of 132 treatment-naive patients with intermediate HCC undergoing combination therapy of TACE and sorafenib were recruited between January 2010 and December 2014. The tumor vascularity was defined according to digital subtraction angiography (DSA) and HFSR was assessed by the national cancer institute common terminology criteria for adverse events (NCI-CTCAE). The Mann-Whitney U test was used to assess the correlation between vascularity and radiologic response; time to radiologic progression (TTP) and overall survival (OS) were evaluated using Kaplan-Meier techniques and compared by log-rank test; factors associated with them were evaluated using multivariate Cox regression analysis. During a median follow up of 17.3 months, it was revealed that hypervascularity and development of ≥2 grade of HFSR within 60 days after sorafenib initiation were favorable predictors for TTP (HR 0.378, p < 0.001; HR 0.627, p = 0.018) and OS (HR 0.499, p = 0.002; HR 0.555, p = 0.004). The median TTP and OS for patients with both were 12.2 and 29.1 months, which were better than patients with either of them (6.0 months, HR 1.74, p = 0.012; 16.5 months, HR 1.73, p = 0.021), as well as those with neither (2.9 months, HR 3.74, p < 0.001; 11.9 months, HR 3.17, p < 0.001). Tumor hypervascularity and development of ≥2 grade of HFSR within 60 days were favorable predictive factors for the combination treatment of TACE and sorafenib, with both of which the patients survived longest and might be the potential candidates.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HZHuihui Zhou
Huihui Zhou
ZZZhilin Zhang
Zhilin Zhang
JZJun Zhang
Jun Zhang
LSLin Sang
Lin Sang
LLLina Liu
Lina Liu
MYMing Yu
Ming Yu
Objectives. To investigate the performance of spleen stiffness (SS) by using two‐dimensional shear‐wave elastography (2D‐SWE) for assessing the severity of gastroesophageal varices (GEVs) after transjugular intrahepatic portosystemic shunt (TIPS). Methods. 102 eligible patients were categorized as in the post‐TIPS short‐term (n = 69) and long‐term (n = 38) follow‐up groups. The performance of SS by using 2D‐SWE for evaluating the severity of GEVs was compared with liver stiffness (LS), spleen stiffness‐to‐liver stiffness ratio (SS/LS), liver stiffness spleen‐diameter‐to‐platelet‐ratio score (LSPS), portal hypertension (PH) risk score, platelet count‐to‐spleen diameter ratio (PSR), and varices risk score by using receiver operating characteristic (ROC) curve and DeLong test. Results. In the post‐TIPS short‐term follow‐up group, area under the receiver operating characteristic curves (AUCs) of SS were 0.585 for mild (cutoff value = 30.3 kPa), 0.655 for moderate (cutoff value = 30.6 kPa), and 0.739 for severe (cutoff value = 31.9 kPa) GEVs, which were higher than other parameters for severe GEVs. AUCs of SS were lower than other parameters for mild and moderate GEVs, but no difference was found (p > 0.05). In the post‐TIPS long‐term follow‐up group, AUCs of SS were 0.778 for mild (cutoff value = 28.9 kPa), 0.82 for moderate (cutoff value = 29.9 kPa), and 0.824 for severe (cutoff value = 37.7 kPa) GEVs, which were higher than other parameters except for severe GEVs. AUC of SS was lower than other parameters for severe GEVs, but no significant difference was found (p > 0.05). Conclusion. SS is an effective noninvasive tool to predict GEV severity during the post‐TIPS follow‐up.

1 January 2011 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
XQXingshun Qi
Xingshun Qi
GHGuohong Han
Guohong Han
ZYZhanxin Yin
Zhanxin Yin
CHChuangye He
Chuangye He
MBMing Bai
Ming Bai
MDMingfan Dai
Mingfan Dai
Acute portal vein thrombosis (PVT) is rarely encountered by clinicians. The most common manifestation of acute PVT is sudden onset of abdominal pain. A computed tomography scan without contrast often shows a high-density material in the portal vein. After injection of contrast agents, absence of luminal enhancement and enlargement of the obstructed portal vein are shown. In this case report, we demonstrated a rare computed tomography finding in which the diameter of the main portal vein was enormously distended to 3-fold that of the aorta in a patient with recent PVT. Despite thrombolysis and anticoagulation were immediately given, portal venous recanalization was not achieved in the patient. After 5 years, variceal bleeding and ascites occurred and liver function had persistently deteriorated. Finally, he died of progressive liver failure. Considering this case, we suggest that an early decision for invasive interventional treatment might be necessary to both increase the rate of portal venous recanalization and improve prognosis, as anticoagulation and thrombolysis therapy failed to recanalize recent PVT.

1 July 2011
Verified
Journal Article
Closed access
MBMing Bai
Ming Bai
GHGuohong Han
Guohong Han
SYShan-Shan Yuan
Shan-Shan Yuan
ZYZhan-Xin Yin
Zhan-Xin Yin
CHChuang-Ye He
Chuang-Ye He
DFDai-Ming Fan
Dai-Ming Fan
To identify the risk factors of early post-TIPS hepatic encephalopathy (HE) and the long-time survival of patients with or without early post-TIPS HE. Consecutive cirrhotic patients who underwent TIPS for variceal rebleeding or refractory ascites in our center from January 2003 to December 2008 were included in this study. More than 60 clinical characteristics were enrolled in univariate analysis and logistic regression analysis to define the risk factors of HE in 3 months after TIPS procedure (early post-TIPS HE). The long-time survival of patients with or without early post-TIPS HE was compared by Cox regression with several covariates. According to our inclusion criteria, 190 patients were included. The median follow-up was 30.5 months. Lower serum concentration of fibrinogen and higher Child-Pugh score were the independent risk factors for suffering early post-TIPS HE. Patients without early post-TIPS HE after TIPS showed better prognosis than those with early post-TIPS HE after TIPS (P = 0.044). Patients with lower serum fibrinogen and higher Child-Pugh score before TIPS might be more probably attacked by early post-TIPS HE which indicated worse long-term survival.